164 related articles for article (PubMed ID: 12194217)
1. Improvement of tumor response by manipulation of tumor oxygenation during photodynamic therapy.
Chen Q; Huang Z; Chen H; Shapiro H; Beckers J; Hetzel FW
Photochem Photobiol; 2002 Aug; 76(2):197-203. PubMed ID: 12194217
[TBL] [Abstract][Full Text] [Related]
2. Hyperoxygenation enhances the tumor cell killing of photofrin-mediated photodynamic therapy.
Huang Z; Chen Q; Shakil A; Chen H; Beckers J; Shapiro H; Hetzel FW
Photochem Photobiol; 2003 Nov; 78(5):496-502. PubMed ID: 14653582
[TBL] [Abstract][Full Text] [Related]
3. Tumor oxygenation changes post-photodynamic therapy.
Chen Q; Chen H; Hetzel FW
Photochem Photobiol; 1996 Jan; 63(1):128-31. PubMed ID: 8577865
[TBL] [Abstract][Full Text] [Related]
4. Enhancing the photodynamic effect of hypericin in tumour spheroids by fractionated light delivery in combination with hyperoxygenation.
Huygens A; Kamuhabwa AR; Van Laethem A; Roskams T; Van Cleynenbreugel B; Van Poppel H; Agostinis P; De Witte PA
Int J Oncol; 2005 Jun; 26(6):1691-7. PubMed ID: 15870887
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity.
Pogue BW; O'Hara JA; Demidenko E; Wilmot CM; Goodwin IA; Chen B; Swartz HM; Hasan T
Cancer Res; 2003 Mar; 63(5):1025-33. PubMed ID: 12615718
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen.
Busch TM; Wileyto EP; Emanuele MJ; Del Piero F; Marconato L; Glatstein E; Koch CJ
Cancer Res; 2002 Dec; 62(24):7273-9. PubMed ID: 12499269
[TBL] [Abstract][Full Text] [Related]
7. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
Ferrario A; von Tiehl KF; Rucker N; Schwarz MA; Gill PS; Gomer CJ
Cancer Res; 2000 Aug; 60(15):4066-9. PubMed ID: 10945611
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic monitoring of Chlorin e6-mediated photodynamic therapy using diffuse optical measurements.
Dong J; Toh HJ; Thong PS; Tee CS; Bi R; Soo KC; Lee K
J Photochem Photobiol B; 2014 Nov; 140():163-72. PubMed ID: 25146878
[TBL] [Abstract][Full Text] [Related]
10. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice.
Fingar VH; Mang TS; Henderson BW
Cancer Res; 1988 Jun; 48(12):3350-4. PubMed ID: 3130983
[TBL] [Abstract][Full Text] [Related]
11. Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
Colussi VC; Feyes DK; Mulvihill JW; Li YS; Kenney ME; Elmets CA; Oleinick NL; Mukhtar H
Photochem Photobiol; 1999 Feb; 69(2):236-41. PubMed ID: 10048316
[TBL] [Abstract][Full Text] [Related]
12. Phototherapy and malignancy: possible enhancement by iron administration and hyperbaric oxygen.
Al-Waili NS; Butler GJ
Med Hypotheses; 2006; 67(5):1148-58. PubMed ID: 16860490
[TBL] [Abstract][Full Text] [Related]
13. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.
Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC
Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323
[TBL] [Abstract][Full Text] [Related]
14. Increasing the efficiency of photodynamic therapy by improved light delivery and oxygen supply using an anticoagulant in a solid tumor model.
Yang L; Wei Y; Xing D; Chen Q
Lasers Surg Med; 2010 Sep; 42(7):671-9. PubMed ID: 20740620
[TBL] [Abstract][Full Text] [Related]
15. Implications of a pre-existing tumor hypoxic fraction on photodynamic therapy.
Fingar VH; Wieman TJ; Park YJ; Henderson BW
J Surg Res; 1992 Nov; 53(5):524-8. PubMed ID: 1434604
[TBL] [Abstract][Full Text] [Related]
16. Early assessment of tumor response to photodynamic therapy using combined diffuse optical and diffuse correlation spectroscopy to predict treatment outcome.
Thong PSP; Lee K; Toh HJ; Dong J; Tee CS; Low KP; Chang PH; Bhuvaneswari R; Tan NC; Soo KC
Oncotarget; 2017 Mar; 8(12):19902-19913. PubMed ID: 28423634
[TBL] [Abstract][Full Text] [Related]
17. Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide ].
Busch TM; Hahn SM; Evans SM; Koch CJ
Cancer Res; 2000 May; 60(10):2636-42. PubMed ID: 10825135
[TBL] [Abstract][Full Text] [Related]
18. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor.
Henderson BW; Fingar VH
Cancer Res; 1987 Jun; 47(12):3110-4. PubMed ID: 3581062
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent.
Henderson BW; Sitnik-Busch TM; Vaughan LA
Photochem Photobiol; 1999 Jul; 70(1):64-71. PubMed ID: 10420844
[TBL] [Abstract][Full Text] [Related]
20. Sensitization of Hypoxic Tumor to Photodynamic Therapy via Oxygen Self-Supply of Fluorinated Photosensitizers.
Liu Z; Xue Y; Wu M; Yang G; Lan M; Zhang W
Biomacromolecules; 2019 Dec; 20(12):4563-4573. PubMed ID: 31710484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
